These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24746556)

  • 21. Epigenetic characteristics and development of embryos cloned from donor cells treated by trichostatin A or 5-aza-2'-deoxycytidine.
    Enright BP; Kubota C; Yang X; Tian XC
    Biol Reprod; 2003 Sep; 69(3):896-901. PubMed ID: 12748129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LPS-induces IL-6 and IL-8 gene expression in bovine endometrial cells "through DNA methylation".
    Wang J; Yan X; Nesengani LT; Ding H; Yang L; Lu W
    Gene; 2018 Nov; 677():266-272. PubMed ID: 30077008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
    Osada H; Tatematsu Y; Sugito N; Horio Y; Takahashi T
    Mol Carcinog; 2005 Dec; 44(4):233-41. PubMed ID: 16163707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
    Lee SH; Kim J; Kim WH; Lee YM
    Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs.
    Deng G; Kakar S; Okudiara K; Choi E; Sleisenger MH; Kim YS
    Clin Cancer Res; 2009 Mar; 15(5):1519-26. PubMed ID: 19223499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Butyrates and decitabine cooperate to induce histone acetylation and granulocytic maturation of t(8;21) acute myeloid leukemia blasts.
    Gozzini A; Santini V
    Ann Hematol; 2005 Dec; 84 Suppl 1():54-60. PubMed ID: 16228241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells.
    Sirchia SM; Ferguson AT; Sironi E; Subramanyan S; Orlandi R; Sukumar S; Sacchi N
    Oncogene; 2000 Mar; 19(12):1556-63. PubMed ID: 10734315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in DNA Methylation and Chromatin Structure of Pro-inflammatory Cytokines Stimulated by LPS in Broiler Peripheral Blood Mononuclear Cells.
    Shen J; Liu Y; Ren X; Gao K; Li Y; Li S; Yao J; Yang X
    Poult Sci; 2016 Jul; 95(7):1636-1645. PubMed ID: 26994192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.
    Konduri SD; Srivenugopal KS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Foster DC; Kisiel W; Ali-Osman F; Kondraganti S; Lakka SS; Rao JS
    Oncogene; 2003 Jul; 22(29):4509-16. PubMed ID: 12881707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells.
    Heller G; Schmidt WM; Ziegler B; Holzer S; Müllauer L; Bilban M; Zielinski CC; Drach J; Zöchbauer-Müller S
    Cancer Res; 2008 Jan; 68(1):44-54. PubMed ID: 18172295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-Aza-2'-deoxycytidine and interleukin-1 cooperate to regulate matrix metalloproteinase-3 gene expression.
    Couillard J; Estève PO; Pradhan S; St-Pierre Y
    Int J Cancer; 2011 Nov; 129(9):2083-92. PubMed ID: 21170958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of interleukin-2-dependency in HTLV-I-infected T cells on gene silencing of thioredoxin-binding protein-2.
    Ahsan MK; Masutani H; Yamaguchi Y; Kim YC; Nosaka K; Matsuoka M; Nishinaka Y; Maeda M; Yodoi J
    Oncogene; 2006 Apr; 25(15):2181-91. PubMed ID: 16314839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-6 expression was regulated by epigenetic mechanisms in response to influenza virus infection or dsRNA treatment.
    Tang B; Zhao R; Sun Y; Zhu Y; Zhong J; Zhao G; Zhu N
    Mol Immunol; 2011 Apr; 48(8):1001-8. PubMed ID: 21353307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence of endogenous mu opioid receptor regulation by epigenetic control of the promoters.
    Hwang CK; Song KY; Kim CS; Choi HS; Guo XH; Law PY; Wei LN; Loh HH
    Mol Cell Biol; 2007 Jul; 27(13):4720-36. PubMed ID: 17452465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of nitric oxide in the epigenetic regulation of THP-1 induced by lipopolysaccharide.
    Rios EC; de Lima TM; Moretti AI; Soriano FG
    Life Sci; 2016 Feb; 147():110-6. PubMed ID: 26826317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone deacetylase activity is required for embryonic stem cell differentiation.
    Lee JH; Hart SR; Skalnik DG
    Genesis; 2004 Jan; 38(1):32-8. PubMed ID: 14755802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
    Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA
    Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pax5 Re-expression in H460 Cells Treated with the Combination of Demethylating Agent and Histone Deacetylase Inhibitor is Associated with the Enhancement of P53 Binding to Pax5 Promoter Region.
    Liang Y; Zeng J; Jelicks L; Ma S; Liu J; Mei J; Perez-Soler R; Zou Y
    Curr Cancer Drug Targets; 2017; 17(2):169-176. PubMed ID: 27029827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a genomic fragment that directs hematopoietic-specific expression of Rac2 and analysis of the DNA methylation profile of the gene locus.
    Ladd PD; Butler JS; Skalnik DG
    Gene; 2004 Oct; 341():323-33. PubMed ID: 15474314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
    J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.